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Background: Revision of arrhythmogenic right ventricular cardiomyopathy (ARVC) Task Force diagnostic criteria in 2010 (TF2010) increased 
the sensitivity for detection of patients at early stages of the disease. The association between TF2010 and symptoms, however, has not been fully 
clarified. Our aim was to review baseline clinical and demographic characteristics of patients enrolled in the Nordic ARVC Registry and assess their 
relation to the early manifestations of the disease.
Methods: Patients with definite ARVC according to TF2010 enrolled in the registry at 8 sites in Denmark, Finland, Norway and Sweden were 
included in the cross-sectional analysis: n=169 (127 families), age 47±15 years, 64% male. Patients were defined as symptomatic based on 
the occurrence of syncope, documented ventricular tachycardia or appropriate ICD therapy (VT) or aborted cardiac arrest (ACA) at any time. The 
performance of TF2010 diagnostic criteria was tested for prediction of symptoms. Minor criteria were assigned 1 point and major criteria 2 points 
when calculating the total diagnostic score.
results: Study population comprised 127 probands and 42 relatives. Mean diagnostic score was 5.9±1.7. Initial disease manifestations were 
VT (n=86, 50.9%), syncope (n=32, 18.9%) or ACA (n=11, 6.4%), while 40 patients did not have any of these symptoms at baseline (23.7%). Male 
gender (OR=2.9; 95%CI 1.3-6.3, p=0.006) and the presence of major imaging criterion (OR=4.1; 95%CI 1.9-8.9, p<0.001) were independently 
associated with either ACA, VT or syncope. Neither ECG abnormalities nor tissue characteristics or family history criteria were predictive of these 
symptoms.
conclusions: In patients with definite ARVC by TF2010 enrolled in the Nordic ARVC Registry, male gender and presence of major imaging 
diagnostic criterion were associated with history of syncope, VT or ACA while none of other diagnostic criteria has shown any significant association 
with the symptoms.
